|Articles|August 2, 2018

Pharmaceutical Technology

  • Pharmaceutical Technology-08-02-2018
  • Volume 42
  • Issue 8

Benchtop Sample Preparation Station

The PrepEngine Mini Sample Prep Station from Distek is suited for assay, impurity, and content uniformity applications.

The PrepEngine Mini Sample Prep Station from Distek is suited for assay, impurity, and content uniformity applications. The instrument was developed through collaborations with pharmaceutical and biotech industry leaders to simplify and speed up the content uniformity sample preparation process.

The compact benchtop design features 10 individually powered, high-output stirring stations that can prepare content uniformity samples up to 90% faster than conventional methods, as stated by the company. The design also includes two high-speed stations with adjustable speeds from 100–6000 rpm and run times from five seconds to four hours.  The prep station comes in multiple designs and sizes, including clear or amber, non-sterilized or sterilized, and 50–500 mL to provide maximum testing flexibility. Users insert and twist a prepared tube to start the test.

Source: Distek

Related to this article

Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation. | Image Credit: ©HockleyMedia24/peopleimages.com -stock.adobe.com
Equivalence test using two one-sided tests are widely used for demonstrating the comparability of treatment effects in different research fields. The method described in the manuscript aims to use simulations in Microsoft Excel to compute power for 2 one-sided tests for two groups with unequal variances.
Complying with International Pharmacopoeias
Susan J. Schniepp, distinguished fellow with Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical, with Parexel, clear up some of the confusion about what does and does not need to be complied with regarding standards set by international pharmacopoeias.
CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 2
Mitigating nitrosamine risk requires assessing each product individually, says Bram Baert, Global Head of Regulatory Affairs at Capsugel, and Sandrine Picco, Senior Analytical Specialist on Capsugel's Innovaform Accelerator Team, in this interview with PharmTech.